As of Sep 19
| +0.86 / +1.82%|
The 13 analysts offering 12-month price forecasts for Medicines Co have a median target of 60.00, with a high estimate of 100.00 and a low estimate of 44.00. The median estimate represents a +24.51% increase from the last price of 48.19.
The current consensus among 14 polled investment analysts is to Buy stock in Medicines Co. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.